Provided by Tiger Fintech (Singapore) Pte. Ltd.

Geron

1.41
+0.06004.44%
Post-market: 1.41-0.0005-0.04%19:57 EDT
Volume:14.98M
Turnover:20.23M
Market Cap:898.04M
PE:-5.22
High:1.41
Open:1.37
Low:1.31
Close:1.35
Loading ...

Why Is Geron Corporation (GERN) the Best Long-Term Penny Stock to Buy According to Hedge Funds?

Insider Monkey
·
07 Jan

Why GERN Stock (GERN) is Skyrocketing

Insider Monkey
·
02 Jan

Is Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?

Insider Monkey
·
01 Jan

Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
01 Jan

Geron (GERN) Stock Surges on Game-Changing New Treatment

TIPRANKS
·
30 Dec 2024

Geron Corp. (GERN) Ends Trading Week Defying Market Bloodbath

Insider Monkey
·
28 Dec 2024

Geron Corporation's (NASDAQ:GERN) Shift From Loss To Profit

Simply Wall St.
·
27 Dec 2024

Is Geron Corp. (GERN) the Biggest Loser of This Week?

Insider Monkey
·
26 Dec 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
20 Dec 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
20 Dec 2024

Geron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72%

Simply Wall St.
·
19 Dec 2024

Sector Update: Health Care Stocks Steady Premarket Friday

MT Newswires Live
·
13 Dec 2024

Geron Price Target Maintained With a $6.00/Share by Needham

Dow Jones
·
13 Dec 2024

Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation

MT Newswires Live
·
13 Dec 2024

BRIEF-EMA'S CHMP Says No Need for Separate Mounjaro Indication for OSA in Obese Adults

Reuters
·
13 Dec 2024

Geron announces positive CHMP opinion for Rytelo

TIPRANKS
·
13 Dec 2024

Geron Announces Positive Chmp Opinion for Rytelo™ (Imetelstat) for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk Mds

THOMSON REUTERS
·
13 Dec 2024

Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS

Business Wire
·
13 Dec 2024

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Zacks
·
13 Dec 2024

Geron (GERN) Receives a Buy from TD Cowen

TIPRANKS
·
11 Dec 2024